Invention Grant
- Patent Title: Modulators of alpha-1 antitrypsin
-
Application No.: US16593118Application Date: 2019-10-04
-
Publication No.: US11623924B2Publication Date: 2023-04-11
- Inventor: Upul Keerthi Bandarage , Cavan McKeon Bligh , Michael John Boyd , Diane M. Boucher , Michael Aaron Brodney , Veronique Damagnez , Lev Tyler Dewey Fanning , Mary Elizabeth Eccles , Robert Francis Fimognari, Jr. , Kevin James Gagnon , Pedro M. Garcia Barrantes , Simon Giroux , Ronald Lee Grey, Jr. , Amy Beth Hall , Sarah Carol Hood , Dennis James Hurley , Joshua Kennedy Hussey , Mac Arthur Johnson, Jr. , Peter Jones , Sarathy Kesavan , Adam Looker , Brad D. Maxwell , John Patrick Maxwell , Ales Medek , Mettachit Navamal , Philippe Marcel Nuhant , Setu Roday , Stefanie Roeper , Rupa Sawant , Yi Shi , Rebecca Jane Swett , Qing Tang , Timothy Lewis Tapley , Stephen A. Thomson , Michael Waldo , Jinwang Xu , Kevin Michael Cottrell
- Applicant: Vertex Pharmaceuticals Incorporated
- Applicant Address: US MA Boston
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Boston
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D519/00
Abstract:
Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).
Public/Granted literature
- US20210179587A1 MODULATORS OF ALPHA-1 ANTITRYPSIN Public/Granted day:2021-06-17
Information query
